AB Partners With Reinsurance Group to Boost Insurance Platform

Zacks
2024-11-14

AllianceBernstein L.P. AB has entered into a partnership with Reinsurance Group of America, Incorporated RGA to expand its insurance business.

Details of AB’s Collaboration

AB has been selected as one of the leading investors in Ruby Reinsurance Company (“Ruby Re”), a reinsurance sidecar vehicle sponsored by RGA. It focuses on the U.S. asset-intensive market. AB plans to manage private alternative assets for RGA’s general account through this transaction.

Per the agreement, AllianceBernstein will be appointing a member to Ruby Re’s board of directors.

Onur Erzan, head of Global Client Group and Bernstein Private Wealth, stated, “Our investment in Ruby Re affirms AB's continued expansion of our insurance platform and growth of our insurance investment management business. Through our partnership with RGA, AB will participate in the growing asset-intensive reinsurance market.”

This move aligns with AB’s growth strategy to enhance its capabilities and top-line growth. This April, the company unveiled Bernstein, a joint venture with Societe Generale SCGLY. This move aims to redefine the landscape of global cash equities and equity research by capitalizing on a synergistic blend of AB's research acumen and SCGLY's extensive equities and derivatives expertise.





AllianceBernstein’s Zacks Rank & Price Performance

Year to date, shares of AB have gained 15.3% compared with the industry's growth of 38.8%.


Image Source: Zacks Investment Research

Currently, AB carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

AllianceBernstein Holding L.P. (AB) : Free Stock Analysis Report

Reinsurance Group of America, Incorporated (RGA) : Free Stock Analysis Report

Societe Generale Group (SCGLY) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10